Skip to main content

Prof. Dr. Michael Heneka

Member

Institute of Neurology

Medical Faculty, University of Bonn University Hospital of Bonn Sigmund-Freud-Strasse 25 53127 Bonn

Website

Prof. Heneka is involved in basic science and translational research with focus on neurodegeneration and neuroinflammation. His major disease of interest and research topics include Alzheimer disease, amyotrophic lateral sclerosis, septic encephalopathy and multiple sclerosis. In clinical neurology, Prof. Heneka holds special expertise in neurodegenerative and autoimmune CNS disorders.

Recent publications

  • NLRP3-mediated glutaminolysis controls microglial phagocytosis to promote Alzheimer's disease progression.

    Immunity

    Authors: Róisín M McManus, Max P Komes, Angelika Griep, Francesco Santarelli, Stephanie Schwartz, Juan Ramón Perea, Johannes C M Schlachetzki, David S Bouvier, Michelle-Amirah Khalil, Mario A Lauterbach, Lea Heinemann, Titus Schlüter, Mehran Shaban Pour, Marta Lovotti, Rainer Stahl, Fraser Duthie, Juan F Rodríguez-Alcázar, Susanne V Schmidt, Jasper Spitzer, Peri Noori, Alberto Maillo, Andreas Boettcher, Brian Herron, John McConville, David Gomez-Cabrero, Jesper Tegnér, Christopher K Glass, Karsten Hiller, Eicke Latz, Michael T Heneka

    View this publication
  • Linking higher amyloid beta 1-38 (Aβ(1-38)) levels to reduced Alzheimer's disease progression risk.

    Alzheimer's & dementia : the journal of the Alzheimer's Association

    Authors: Luisa Sophie Schneider, Silka Dawn Freiesleben, Gerard van Breukelen, Xiao Wang, Frederic Brosseron, Michael T Heneka, Stefan Teipel, Luca Kleineidam, Melina Stark, Nina Roy-Kluth, Michael Wagner, Annika Spottke, Matthias Schmid, Sandra Roeske, Christoph Laske, Matthias H Munk, Robert Perneczky, Boris-Stephan Rauchmann, Katharina Buerger, Daniel Janowitz, Emrah Düzel, Wenzel Glanz, Frank Jessen, Ayda Rostamzadeh, Jens Wiltfang, Claudia Bartels, Ingo Kilimann, Anja Schneider, Klaus Fliessbach, Josef Priller, Eike Jakob Spruth, Julian Hellmann-Regen, Oliver Peters

    View this publication
  • CSF biomarkers are differentially linked to brain areas high and low in noradrenaline, dopamine and serotonin across the Alzheimer's disease spectrum.

    Brain communications

    Authors: Lena Haag, Elisa Lancini, Renat Yakupov, Gabriel Ziegler, Yeo-Jin Yi, Falk Lüsebrink, Wenzel Glanz, Oliver Peters, Eike Jakob Spruth, Slawek Altenstein, Josef Priller, Luisa Sophie Schneider, Xiao Wang, Lukas Preis, Frederic Brosseron, Nina Roy-Kluth, Klaus Fliessbach, Michael Wagner, Steffen Wolfsgruber, Luca Kleineidam, Alfredo Ramirez, Annika Spottke, Frank Jessen, Jens Wiltfang, Anja Schneider, Niels Hansen, Ayda Rostamzadeh, Katharina Buerger, Michael Ewers, Robert Perneczky, Daniel Janowitz, Boris-Stephan Rauchmann, Stefan Teipel, Ingo Kilimann, Doreen Goerss, Christoph Laske, Matthias H Munk, Michael Heneka, Peter Dechent, Stefan Hetzer, Klaus Scheffler, Emrah Düzel, Matthew J Betts, Dorothea Hämmerer

    View this publication